Status:
COMPLETED
A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
Lead Sponsor:
Pfizer
Conditions:
Acute Bronchitis
Eligibility:
All Genders
16-80 years
Phase:
PHASE3
Brief Summary
To evaluate the clinical efficacy and safety in patients with Acute Bronchitis or Secondary Infection of Chronic Respiratory Diseases receiving a dose of 2 g of azithromycin in the SR formulation.
Eligibility Criteria
Inclusion
- Patients who were diagnosed as mild or moderate in severity by the classification of infection of the Japanese Society of Chemotherapy guidelines for the evaluation methods of new antibacterial drug (established in 1997).
Exclusion
- Severe underlying disease; patients in which drug clinical evaluation is difficult because of confounding diseases.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00360464
Start Date
October 1 2006
End Date
June 1 2007
Last Update
April 21 2011
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Hitachi-Naka, Ibaraki, Japan, 312-0057
2
Pfizer Investigational Site
Kasama, Ibaraki, Japan, 309-1793
3
Pfizer Investigational Site
Moriya, Ibaraki, Japan, 302-0118
4
Pfizer Investigational Site
Toride, Ibaraki, Japan, 302-0005